Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03569813 · ClinicalTrials.gov registry record · NA
Pre-exposure Prophylaxis (PrEP) at Home
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 318
- Enrollment target
NCT03569813 is a NA study that has completed, run by Emory University. The registered enrollment target is 318 participants.
The verdict
NCT03569813, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 318 participants
- Enrollment target
Study Summary
This study is a randomized clinical trial of PrEP@Home, a home care system for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP). Individuals entering into PrEP care at an initial in-person study visit will be randomized to the PrEP@Home system for home-based PrEP care follow-up visits or to the control standard of care for clinic-based follow-up visits. The primary aim of this study is to assess protective levels of PrEP medication for the intervention arm compared to the control arm.
Interventions
- OTHER Standard of Care
- BEHAVIORAL PrEP@Home System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2019-04-26 |
| Est. Completion | 2023-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03569813
The ClinicalTrials.gov registry entry for NCT03569813 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT03569813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03569813 about?
NCT03569813 is a clinical study titled "Pre-exposure Prophylaxis (PrEP) at Home". This study is a randomized clinical trial of PrEP@Home, a home care system for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP). Individuals entering into PrEP care at an initial in-person study visit will be randomized to the PrEP@Home system for home-based PrEP care follow-up vis...
What is the current status of trial NCT03569813?
This trial is currently completed. It is a NA study. The enrollment target is 318 participants. The study started on 2019-04-26. Estimated completion is 2023-04-15.
What interventions are being tested in trial NCT03569813?
The interventions under investigation include: Standard of Care (OTHER), PrEP@Home System (BEHAVIORAL).
Who is sponsoring clinical trial NCT03569813?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.